Review



skeletal muscle cell growth kit  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    ATCC skeletal muscle cell growth kit
    Effect of rADAMTS-1 on MuSCs following BaCl 2 -induced TA <t>muscle</t> injury. Groups included NC, BaCl 2 , and two treatment groups receiving rADAMTS-1 (L) and (H). Daily intraperitoneal injections of rADAMTS-1 were initiated immediately after injury and continued until the designated time point for analysis. (A) Flow cytometry analysis of MuSCs isolated from injured TA muscles, defined by surface marker expression (CD45 − /CD31 − /Sca1 − /VCAM1 + ). (B) Representative gating strategy for MuSCs across experimental groups at different time points. (C) Relative number of MuSCs normalized to the NC group over time. Statistical significance was determined using one-way analysis of variance, followed by Tukey's post hoc test: * P<0.05, ** P<0.01 and *** P<0.001 vs. NC; ## P<0.01 and ### P<0.001 vs. BaCl 2 group. (D) Representative immunofluorescence images of Pax7 + cells in injured TA muscle at different time points (scale bar, 25 μ m). (E) Quantification of Pax7 + <t>cell</t> percentages over time. Statistical significance was determined using one-way analysis of variance with Tukey's post hoc test: * P<0.05 and *** P<0.001 vs. NC; ### P<0.001 vs. BaCl 2 ; ††† P<0.001 vs. rADAMTS-1 (L). ADAMTS-1, a disintegrin and metalloproteinase with thrombospondin motifs 1; rADAMTS-1, recombinant ADAMTS-1; MuSCs, <t>skeletal</t> muscle satellite cells; BaCl 2, barium chloride; TA, tibialis anterior; NC, non-injured control; rADAMTS-1 (L), rADAMTS-1 at 5 mg/kg; rADAMTS-1 (H), rADAMTS-1 at 10 mg/kg; CD, cluster of differentiation; Sca1, stem cell antigen 1; VCAM1, vascular cell adhesion molecule; Pax7, paired box protein.
    Skeletal Muscle Cell Growth Kit, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 25 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/skeletal muscle cell growth kit/product/ATCC
    Average 94 stars, based on 25 article reviews
    skeletal muscle cell growth kit - by Bioz Stars, 2026-02
    94/100 stars

    Images

    1) Product Images from "Recombinant ADAMTS-1 promotes muscle regeneration accompanied by downregulation of Notch signaling"

    Article Title: Recombinant ADAMTS-1 promotes muscle regeneration accompanied by downregulation of Notch signaling

    Journal: International Journal of Molecular Medicine

    doi: 10.3892/ijmm.2025.5718

    Effect of rADAMTS-1 on MuSCs following BaCl 2 -induced TA muscle injury. Groups included NC, BaCl 2 , and two treatment groups receiving rADAMTS-1 (L) and (H). Daily intraperitoneal injections of rADAMTS-1 were initiated immediately after injury and continued until the designated time point for analysis. (A) Flow cytometry analysis of MuSCs isolated from injured TA muscles, defined by surface marker expression (CD45 − /CD31 − /Sca1 − /VCAM1 + ). (B) Representative gating strategy for MuSCs across experimental groups at different time points. (C) Relative number of MuSCs normalized to the NC group over time. Statistical significance was determined using one-way analysis of variance, followed by Tukey's post hoc test: * P<0.05, ** P<0.01 and *** P<0.001 vs. NC; ## P<0.01 and ### P<0.001 vs. BaCl 2 group. (D) Representative immunofluorescence images of Pax7 + cells in injured TA muscle at different time points (scale bar, 25 μ m). (E) Quantification of Pax7 + cell percentages over time. Statistical significance was determined using one-way analysis of variance with Tukey's post hoc test: * P<0.05 and *** P<0.001 vs. NC; ### P<0.001 vs. BaCl 2 ; ††† P<0.001 vs. rADAMTS-1 (L). ADAMTS-1, a disintegrin and metalloproteinase with thrombospondin motifs 1; rADAMTS-1, recombinant ADAMTS-1; MuSCs, skeletal muscle satellite cells; BaCl 2, barium chloride; TA, tibialis anterior; NC, non-injured control; rADAMTS-1 (L), rADAMTS-1 at 5 mg/kg; rADAMTS-1 (H), rADAMTS-1 at 10 mg/kg; CD, cluster of differentiation; Sca1, stem cell antigen 1; VCAM1, vascular cell adhesion molecule; Pax7, paired box protein.
    Figure Legend Snippet: Effect of rADAMTS-1 on MuSCs following BaCl 2 -induced TA muscle injury. Groups included NC, BaCl 2 , and two treatment groups receiving rADAMTS-1 (L) and (H). Daily intraperitoneal injections of rADAMTS-1 were initiated immediately after injury and continued until the designated time point for analysis. (A) Flow cytometry analysis of MuSCs isolated from injured TA muscles, defined by surface marker expression (CD45 − /CD31 − /Sca1 − /VCAM1 + ). (B) Representative gating strategy for MuSCs across experimental groups at different time points. (C) Relative number of MuSCs normalized to the NC group over time. Statistical significance was determined using one-way analysis of variance, followed by Tukey's post hoc test: * P<0.05, ** P<0.01 and *** P<0.001 vs. NC; ## P<0.01 and ### P<0.001 vs. BaCl 2 group. (D) Representative immunofluorescence images of Pax7 + cells in injured TA muscle at different time points (scale bar, 25 μ m). (E) Quantification of Pax7 + cell percentages over time. Statistical significance was determined using one-way analysis of variance with Tukey's post hoc test: * P<0.05 and *** P<0.001 vs. NC; ### P<0.001 vs. BaCl 2 ; ††† P<0.001 vs. rADAMTS-1 (L). ADAMTS-1, a disintegrin and metalloproteinase with thrombospondin motifs 1; rADAMTS-1, recombinant ADAMTS-1; MuSCs, skeletal muscle satellite cells; BaCl 2, barium chloride; TA, tibialis anterior; NC, non-injured control; rADAMTS-1 (L), rADAMTS-1 at 5 mg/kg; rADAMTS-1 (H), rADAMTS-1 at 10 mg/kg; CD, cluster of differentiation; Sca1, stem cell antigen 1; VCAM1, vascular cell adhesion molecule; Pax7, paired box protein.

    Techniques Used: Flow Cytometry, Isolation, Muscles, Marker, Expressing, Immunofluorescence, Recombinant, Control



    Similar Products

    skeletal muscle cell growth kit  (ATCC)
    94
    ATCC skeletal muscle cell growth kit
    Effect of rADAMTS-1 on MuSCs following BaCl 2 -induced TA <t>muscle</t> injury. Groups included NC, BaCl 2 , and two treatment groups receiving rADAMTS-1 (L) and (H). Daily intraperitoneal injections of rADAMTS-1 were initiated immediately after injury and continued until the designated time point for analysis. (A) Flow cytometry analysis of MuSCs isolated from injured TA muscles, defined by surface marker expression (CD45 − /CD31 − /Sca1 − /VCAM1 + ). (B) Representative gating strategy for MuSCs across experimental groups at different time points. (C) Relative number of MuSCs normalized to the NC group over time. Statistical significance was determined using one-way analysis of variance, followed by Tukey's post hoc test: * P<0.05, ** P<0.01 and *** P<0.001 vs. NC; ## P<0.01 and ### P<0.001 vs. BaCl 2 group. (D) Representative immunofluorescence images of Pax7 + cells in injured TA muscle at different time points (scale bar, 25 μ m). (E) Quantification of Pax7 + <t>cell</t> percentages over time. Statistical significance was determined using one-way analysis of variance with Tukey's post hoc test: * P<0.05 and *** P<0.001 vs. NC; ### P<0.001 vs. BaCl 2 ; ††† P<0.001 vs. rADAMTS-1 (L). ADAMTS-1, a disintegrin and metalloproteinase with thrombospondin motifs 1; rADAMTS-1, recombinant ADAMTS-1; MuSCs, <t>skeletal</t> muscle satellite cells; BaCl 2, barium chloride; TA, tibialis anterior; NC, non-injured control; rADAMTS-1 (L), rADAMTS-1 at 5 mg/kg; rADAMTS-1 (H), rADAMTS-1 at 10 mg/kg; CD, cluster of differentiation; Sca1, stem cell antigen 1; VCAM1, vascular cell adhesion molecule; Pax7, paired box protein.
    Skeletal Muscle Cell Growth Kit, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/skeletal muscle cell growth kit/product/ATCC
    Average 94 stars, based on 1 article reviews
    skeletal muscle cell growth kit - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    human muscle growth medium  (PromoCell)
    94
    PromoCell human muscle growth medium
    Effect of rADAMTS-1 on MuSCs following BaCl 2 -induced TA <t>muscle</t> injury. Groups included NC, BaCl 2 , and two treatment groups receiving rADAMTS-1 (L) and (H). Daily intraperitoneal injections of rADAMTS-1 were initiated immediately after injury and continued until the designated time point for analysis. (A) Flow cytometry analysis of MuSCs isolated from injured TA muscles, defined by surface marker expression (CD45 − /CD31 − /Sca1 − /VCAM1 + ). (B) Representative gating strategy for MuSCs across experimental groups at different time points. (C) Relative number of MuSCs normalized to the NC group over time. Statistical significance was determined using one-way analysis of variance, followed by Tukey's post hoc test: * P<0.05, ** P<0.01 and *** P<0.001 vs. NC; ## P<0.01 and ### P<0.001 vs. BaCl 2 group. (D) Representative immunofluorescence images of Pax7 + cells in injured TA muscle at different time points (scale bar, 25 μ m). (E) Quantification of Pax7 + <t>cell</t> percentages over time. Statistical significance was determined using one-way analysis of variance with Tukey's post hoc test: * P<0.05 and *** P<0.001 vs. NC; ### P<0.001 vs. BaCl 2 ; ††† P<0.001 vs. rADAMTS-1 (L). ADAMTS-1, a disintegrin and metalloproteinase with thrombospondin motifs 1; rADAMTS-1, recombinant ADAMTS-1; MuSCs, <t>skeletal</t> muscle satellite cells; BaCl 2, barium chloride; TA, tibialis anterior; NC, non-injured control; rADAMTS-1 (L), rADAMTS-1 at 5 mg/kg; rADAMTS-1 (H), rADAMTS-1 at 10 mg/kg; CD, cluster of differentiation; Sca1, stem cell antigen 1; VCAM1, vascular cell adhesion molecule; Pax7, paired box protein.
    Human Muscle Growth Medium, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human muscle growth medium/product/PromoCell
    Average 94 stars, based on 1 article reviews
    human muscle growth medium - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    2d myotube differentiation media solution composition immortalized myoblast growth media skeletal muscle cell growth medium kit  (PromoCell)
    94
    PromoCell 2d myotube differentiation media solution composition immortalized myoblast growth media skeletal muscle cell growth medium kit
    Effect of rADAMTS-1 on MuSCs following BaCl 2 -induced TA <t>muscle</t> injury. Groups included NC, BaCl 2 , and two treatment groups receiving rADAMTS-1 (L) and (H). Daily intraperitoneal injections of rADAMTS-1 were initiated immediately after injury and continued until the designated time point for analysis. (A) Flow cytometry analysis of MuSCs isolated from injured TA muscles, defined by surface marker expression (CD45 − /CD31 − /Sca1 − /VCAM1 + ). (B) Representative gating strategy for MuSCs across experimental groups at different time points. (C) Relative number of MuSCs normalized to the NC group over time. Statistical significance was determined using one-way analysis of variance, followed by Tukey's post hoc test: * P<0.05, ** P<0.01 and *** P<0.001 vs. NC; ## P<0.01 and ### P<0.001 vs. BaCl 2 group. (D) Representative immunofluorescence images of Pax7 + cells in injured TA muscle at different time points (scale bar, 25 μ m). (E) Quantification of Pax7 + <t>cell</t> percentages over time. Statistical significance was determined using one-way analysis of variance with Tukey's post hoc test: * P<0.05 and *** P<0.001 vs. NC; ### P<0.001 vs. BaCl 2 ; ††† P<0.001 vs. rADAMTS-1 (L). ADAMTS-1, a disintegrin and metalloproteinase with thrombospondin motifs 1; rADAMTS-1, recombinant ADAMTS-1; MuSCs, <t>skeletal</t> muscle satellite cells; BaCl 2, barium chloride; TA, tibialis anterior; NC, non-injured control; rADAMTS-1 (L), rADAMTS-1 at 5 mg/kg; rADAMTS-1 (H), rADAMTS-1 at 10 mg/kg; CD, cluster of differentiation; Sca1, stem cell antigen 1; VCAM1, vascular cell adhesion molecule; Pax7, paired box protein.
    2d Myotube Differentiation Media Solution Composition Immortalized Myoblast Growth Media Skeletal Muscle Cell Growth Medium Kit, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/2d myotube differentiation media solution composition immortalized myoblast growth media skeletal muscle cell growth medium kit/product/PromoCell
    Average 94 stars, based on 1 article reviews
    2d myotube differentiation media solution composition immortalized myoblast growth media skeletal muscle cell growth medium kit - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    growth media  (PromoCell)
    94
    PromoCell growth media
    Effect of rADAMTS-1 on MuSCs following BaCl 2 -induced TA <t>muscle</t> injury. Groups included NC, BaCl 2 , and two treatment groups receiving rADAMTS-1 (L) and (H). Daily intraperitoneal injections of rADAMTS-1 were initiated immediately after injury and continued until the designated time point for analysis. (A) Flow cytometry analysis of MuSCs isolated from injured TA muscles, defined by surface marker expression (CD45 − /CD31 − /Sca1 − /VCAM1 + ). (B) Representative gating strategy for MuSCs across experimental groups at different time points. (C) Relative number of MuSCs normalized to the NC group over time. Statistical significance was determined using one-way analysis of variance, followed by Tukey's post hoc test: * P<0.05, ** P<0.01 and *** P<0.001 vs. NC; ## P<0.01 and ### P<0.001 vs. BaCl 2 group. (D) Representative immunofluorescence images of Pax7 + cells in injured TA muscle at different time points (scale bar, 25 μ m). (E) Quantification of Pax7 + <t>cell</t> percentages over time. Statistical significance was determined using one-way analysis of variance with Tukey's post hoc test: * P<0.05 and *** P<0.001 vs. NC; ### P<0.001 vs. BaCl 2 ; ††† P<0.001 vs. rADAMTS-1 (L). ADAMTS-1, a disintegrin and metalloproteinase with thrombospondin motifs 1; rADAMTS-1, recombinant ADAMTS-1; MuSCs, <t>skeletal</t> muscle satellite cells; BaCl 2, barium chloride; TA, tibialis anterior; NC, non-injured control; rADAMTS-1 (L), rADAMTS-1 at 5 mg/kg; rADAMTS-1 (H), rADAMTS-1 at 10 mg/kg; CD, cluster of differentiation; Sca1, stem cell antigen 1; VCAM1, vascular cell adhesion molecule; Pax7, paired box protein.
    Growth Media, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/growth media/product/PromoCell
    Average 94 stars, based on 1 article reviews
    growth media - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    skeletal muscle cell growth media kit  (PromoCell)
    94
    PromoCell skeletal muscle cell growth media kit
    Effect of rADAMTS-1 on MuSCs following BaCl 2 -induced TA <t>muscle</t> injury. Groups included NC, BaCl 2 , and two treatment groups receiving rADAMTS-1 (L) and (H). Daily intraperitoneal injections of rADAMTS-1 were initiated immediately after injury and continued until the designated time point for analysis. (A) Flow cytometry analysis of MuSCs isolated from injured TA muscles, defined by surface marker expression (CD45 − /CD31 − /Sca1 − /VCAM1 + ). (B) Representative gating strategy for MuSCs across experimental groups at different time points. (C) Relative number of MuSCs normalized to the NC group over time. Statistical significance was determined using one-way analysis of variance, followed by Tukey's post hoc test: * P<0.05, ** P<0.01 and *** P<0.001 vs. NC; ## P<0.01 and ### P<0.001 vs. BaCl 2 group. (D) Representative immunofluorescence images of Pax7 + cells in injured TA muscle at different time points (scale bar, 25 μ m). (E) Quantification of Pax7 + <t>cell</t> percentages over time. Statistical significance was determined using one-way analysis of variance with Tukey's post hoc test: * P<0.05 and *** P<0.001 vs. NC; ### P<0.001 vs. BaCl 2 ; ††† P<0.001 vs. rADAMTS-1 (L). ADAMTS-1, a disintegrin and metalloproteinase with thrombospondin motifs 1; rADAMTS-1, recombinant ADAMTS-1; MuSCs, <t>skeletal</t> muscle satellite cells; BaCl 2, barium chloride; TA, tibialis anterior; NC, non-injured control; rADAMTS-1 (L), rADAMTS-1 at 5 mg/kg; rADAMTS-1 (H), rADAMTS-1 at 10 mg/kg; CD, cluster of differentiation; Sca1, stem cell antigen 1; VCAM1, vascular cell adhesion molecule; Pax7, paired box protein.
    Skeletal Muscle Cell Growth Media Kit, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/skeletal muscle cell growth media kit/product/PromoCell
    Average 94 stars, based on 1 article reviews
    skeletal muscle cell growth media kit - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    skeletal muscle cell growth medium28 29  (PromoCell)
    94
    PromoCell skeletal muscle cell growth medium28 29
    Effect of rADAMTS-1 on MuSCs following BaCl 2 -induced TA <t>muscle</t> injury. Groups included NC, BaCl 2 , and two treatment groups receiving rADAMTS-1 (L) and (H). Daily intraperitoneal injections of rADAMTS-1 were initiated immediately after injury and continued until the designated time point for analysis. (A) Flow cytometry analysis of MuSCs isolated from injured TA muscles, defined by surface marker expression (CD45 − /CD31 − /Sca1 − /VCAM1 + ). (B) Representative gating strategy for MuSCs across experimental groups at different time points. (C) Relative number of MuSCs normalized to the NC group over time. Statistical significance was determined using one-way analysis of variance, followed by Tukey's post hoc test: * P<0.05, ** P<0.01 and *** P<0.001 vs. NC; ## P<0.01 and ### P<0.001 vs. BaCl 2 group. (D) Representative immunofluorescence images of Pax7 + cells in injured TA muscle at different time points (scale bar, 25 μ m). (E) Quantification of Pax7 + <t>cell</t> percentages over time. Statistical significance was determined using one-way analysis of variance with Tukey's post hoc test: * P<0.05 and *** P<0.001 vs. NC; ### P<0.001 vs. BaCl 2 ; ††† P<0.001 vs. rADAMTS-1 (L). ADAMTS-1, a disintegrin and metalloproteinase with thrombospondin motifs 1; rADAMTS-1, recombinant ADAMTS-1; MuSCs, <t>skeletal</t> muscle satellite cells; BaCl 2, barium chloride; TA, tibialis anterior; NC, non-injured control; rADAMTS-1 (L), rADAMTS-1 at 5 mg/kg; rADAMTS-1 (H), rADAMTS-1 at 10 mg/kg; CD, cluster of differentiation; Sca1, stem cell antigen 1; VCAM1, vascular cell adhesion molecule; Pax7, paired box protein.
    Skeletal Muscle Cell Growth Medium28 29, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/skeletal muscle cell growth medium28 29/product/PromoCell
    Average 94 stars, based on 1 article reviews
    skeletal muscle cell growth medium28 29 - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    skeletal muscle growth media  (PromoCell)
    94
    PromoCell skeletal muscle growth media
    Effect of rADAMTS-1 on MuSCs following BaCl 2 -induced TA <t>muscle</t> injury. Groups included NC, BaCl 2 , and two treatment groups receiving rADAMTS-1 (L) and (H). Daily intraperitoneal injections of rADAMTS-1 were initiated immediately after injury and continued until the designated time point for analysis. (A) Flow cytometry analysis of MuSCs isolated from injured TA muscles, defined by surface marker expression (CD45 − /CD31 − /Sca1 − /VCAM1 + ). (B) Representative gating strategy for MuSCs across experimental groups at different time points. (C) Relative number of MuSCs normalized to the NC group over time. Statistical significance was determined using one-way analysis of variance, followed by Tukey's post hoc test: * P<0.05, ** P<0.01 and *** P<0.001 vs. NC; ## P<0.01 and ### P<0.001 vs. BaCl 2 group. (D) Representative immunofluorescence images of Pax7 + cells in injured TA muscle at different time points (scale bar, 25 μ m). (E) Quantification of Pax7 + <t>cell</t> percentages over time. Statistical significance was determined using one-way analysis of variance with Tukey's post hoc test: * P<0.05 and *** P<0.001 vs. NC; ### P<0.001 vs. BaCl 2 ; ††† P<0.001 vs. rADAMTS-1 (L). ADAMTS-1, a disintegrin and metalloproteinase with thrombospondin motifs 1; rADAMTS-1, recombinant ADAMTS-1; MuSCs, <t>skeletal</t> muscle satellite cells; BaCl 2, barium chloride; TA, tibialis anterior; NC, non-injured control; rADAMTS-1 (L), rADAMTS-1 at 5 mg/kg; rADAMTS-1 (H), rADAMTS-1 at 10 mg/kg; CD, cluster of differentiation; Sca1, stem cell antigen 1; VCAM1, vascular cell adhesion molecule; Pax7, paired box protein.
    Skeletal Muscle Growth Media, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/skeletal muscle growth media/product/PromoCell
    Average 94 stars, based on 1 article reviews
    skeletal muscle growth media - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    general media  (PromoCell)
    94
    PromoCell general media
    Effect of rADAMTS-1 on MuSCs following BaCl 2 -induced TA <t>muscle</t> injury. Groups included NC, BaCl 2 , and two treatment groups receiving rADAMTS-1 (L) and (H). Daily intraperitoneal injections of rADAMTS-1 were initiated immediately after injury and continued until the designated time point for analysis. (A) Flow cytometry analysis of MuSCs isolated from injured TA muscles, defined by surface marker expression (CD45 − /CD31 − /Sca1 − /VCAM1 + ). (B) Representative gating strategy for MuSCs across experimental groups at different time points. (C) Relative number of MuSCs normalized to the NC group over time. Statistical significance was determined using one-way analysis of variance, followed by Tukey's post hoc test: * P<0.05, ** P<0.01 and *** P<0.001 vs. NC; ## P<0.01 and ### P<0.001 vs. BaCl 2 group. (D) Representative immunofluorescence images of Pax7 + cells in injured TA muscle at different time points (scale bar, 25 μ m). (E) Quantification of Pax7 + <t>cell</t> percentages over time. Statistical significance was determined using one-way analysis of variance with Tukey's post hoc test: * P<0.05 and *** P<0.001 vs. NC; ### P<0.001 vs. BaCl 2 ; ††† P<0.001 vs. rADAMTS-1 (L). ADAMTS-1, a disintegrin and metalloproteinase with thrombospondin motifs 1; rADAMTS-1, recombinant ADAMTS-1; MuSCs, <t>skeletal</t> muscle satellite cells; BaCl 2, barium chloride; TA, tibialis anterior; NC, non-injured control; rADAMTS-1 (L), rADAMTS-1 at 5 mg/kg; rADAMTS-1 (H), rADAMTS-1 at 10 mg/kg; CD, cluster of differentiation; Sca1, stem cell antigen 1; VCAM1, vascular cell adhesion molecule; Pax7, paired box protein.
    General Media, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/general media/product/PromoCell
    Average 94 stars, based on 1 article reviews
    general media - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Effect of rADAMTS-1 on MuSCs following BaCl 2 -induced TA muscle injury. Groups included NC, BaCl 2 , and two treatment groups receiving rADAMTS-1 (L) and (H). Daily intraperitoneal injections of rADAMTS-1 were initiated immediately after injury and continued until the designated time point for analysis. (A) Flow cytometry analysis of MuSCs isolated from injured TA muscles, defined by surface marker expression (CD45 − /CD31 − /Sca1 − /VCAM1 + ). (B) Representative gating strategy for MuSCs across experimental groups at different time points. (C) Relative number of MuSCs normalized to the NC group over time. Statistical significance was determined using one-way analysis of variance, followed by Tukey's post hoc test: * P<0.05, ** P<0.01 and *** P<0.001 vs. NC; ## P<0.01 and ### P<0.001 vs. BaCl 2 group. (D) Representative immunofluorescence images of Pax7 + cells in injured TA muscle at different time points (scale bar, 25 μ m). (E) Quantification of Pax7 + cell percentages over time. Statistical significance was determined using one-way analysis of variance with Tukey's post hoc test: * P<0.05 and *** P<0.001 vs. NC; ### P<0.001 vs. BaCl 2 ; ††† P<0.001 vs. rADAMTS-1 (L). ADAMTS-1, a disintegrin and metalloproteinase with thrombospondin motifs 1; rADAMTS-1, recombinant ADAMTS-1; MuSCs, skeletal muscle satellite cells; BaCl 2, barium chloride; TA, tibialis anterior; NC, non-injured control; rADAMTS-1 (L), rADAMTS-1 at 5 mg/kg; rADAMTS-1 (H), rADAMTS-1 at 10 mg/kg; CD, cluster of differentiation; Sca1, stem cell antigen 1; VCAM1, vascular cell adhesion molecule; Pax7, paired box protein.

    Journal: International Journal of Molecular Medicine

    Article Title: Recombinant ADAMTS-1 promotes muscle regeneration accompanied by downregulation of Notch signaling

    doi: 10.3892/ijmm.2025.5718

    Figure Lengend Snippet: Effect of rADAMTS-1 on MuSCs following BaCl 2 -induced TA muscle injury. Groups included NC, BaCl 2 , and two treatment groups receiving rADAMTS-1 (L) and (H). Daily intraperitoneal injections of rADAMTS-1 were initiated immediately after injury and continued until the designated time point for analysis. (A) Flow cytometry analysis of MuSCs isolated from injured TA muscles, defined by surface marker expression (CD45 − /CD31 − /Sca1 − /VCAM1 + ). (B) Representative gating strategy for MuSCs across experimental groups at different time points. (C) Relative number of MuSCs normalized to the NC group over time. Statistical significance was determined using one-way analysis of variance, followed by Tukey's post hoc test: * P<0.05, ** P<0.01 and *** P<0.001 vs. NC; ## P<0.01 and ### P<0.001 vs. BaCl 2 group. (D) Representative immunofluorescence images of Pax7 + cells in injured TA muscle at different time points (scale bar, 25 μ m). (E) Quantification of Pax7 + cell percentages over time. Statistical significance was determined using one-way analysis of variance with Tukey's post hoc test: * P<0.05 and *** P<0.001 vs. NC; ### P<0.001 vs. BaCl 2 ; ††† P<0.001 vs. rADAMTS-1 (L). ADAMTS-1, a disintegrin and metalloproteinase with thrombospondin motifs 1; rADAMTS-1, recombinant ADAMTS-1; MuSCs, skeletal muscle satellite cells; BaCl 2, barium chloride; TA, tibialis anterior; NC, non-injured control; rADAMTS-1 (L), rADAMTS-1 at 5 mg/kg; rADAMTS-1 (H), rADAMTS-1 at 10 mg/kg; CD, cluster of differentiation; Sca1, stem cell antigen 1; VCAM1, vascular cell adhesion molecule; Pax7, paired box protein.

    Article Snippet: Primary skeletal muscle cells (cat. no. PCS-950-010; ATCC) were cultured in a complete expansion medium (cat. no. PCS-500-030; ATCC) using a primary skeletal muscle cell growth kit (cat. no. PCS-950-040; ATCC).

    Techniques: Flow Cytometry, Isolation, Muscles, Marker, Expressing, Immunofluorescence, Recombinant, Control